Advanced mutant receptor activator of nuclear factor kappa‐Β ligand development with low affinity for osteoprotegerin
Saved in:
Main Authors: | Yuria Jang, Yongjin Cho, Youngjong Ko, Yeonhee Moon, Chang‐Moon Lee, Wonbong Lim |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2025-01-01
|
Series: | Clinical and Translational Medicine |
Online Access: | https://doi.org/10.1002/ctm2.70195 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Models of neuroinflammation for the assessment of kappa-opioid receptor ligands
by: K. Yu. Kalitin, et al.
Published: (2023-05-01) -
Correlation between Receptor Activator of Nuclear Factor-κβ Ligand (RANKL), and Osteoprotegerin (OPG) with Cartilage Degradation in Rheumatoid Arthritis Patients
by: Rudy Hidayat, et al.
Published: (2015-01-01) -
Correlation between Receptor Activator of Nuclear Factor-κβ Ligand (RANKL), and Osteoprotegerin (OPG) with Cartilage Degradation in Rheumatoid Arthritis Patients
by: Rudy Hidayat, et al.
Published: (2015-01-01) -
Ectopic overexpression of CD133 in HNSCC makes it resistant to commonly used chemotherapeutics
by: Junyoung Lee, et al.
Published: (2017-04-01) -
How THC works: Explaining ligand affinity for, and partial agonism of, cannabinoid receptor 1
by: Farsheed Shahbazi-Raz, et al.
Published: (2025-07-01)